InvestorsHub Logo
Followers 34
Posts 6200
Boards Moderated 0
Alias Born 07/05/2004

Re: None

Saturday, 04/24/2021 1:01:33 PM

Saturday, April 24, 2021 1:01:33 PM

Post# of 12437
Can't wait to hear an update about this soon..that's 3 doctors in separate research projects that found evidence and have data on this.. it will be huge..

"During recent testing at The University of British Columbia, where photo receptors were transplanted into animal models, it was observed that AAGP® may have had a role in protecting xenografts and allografts from immune rejection from the host immune system, thereby helping the graft to survive and mature in the transplant recipient.
Immune rejection, leading to graft versus host disease (GVHD) is a primary concern present in almost all transplants, requiring the use of immunosuppressants such as cyclosporin, tacrolimus and rapamycin."

https://markets.businessinsider.com/news/stocks/protokinetix-files-for-patent-protection-for-the-use-of-aagp-in-transplant-medicine-1028892940